“…Almost all patients with AD will develop neuropsychiatric symptoms (NPSs) [2] .Studies have found a prevalence of NPS in dementia between 50% and 80% [3] .They have been found to occur before cognitive decline [4] .Some studies have suggested that speci c NPS may be useful as early predictors of AD or dementia [5] .NPSs refers to non-cognitive mental and behavioral symptoms, which involve perception, emotion, behavior and other elds, mainly including hallucinations, delusions, depression, apathy and other symptoms [6] .Studies suggest that NPS may worsen cognitive symptoms and functional decline and have associated these symptoms with accelerated mortality [7] .Moreover, NPS can be di cult to treat [8] .While psychotropic drugs may temporarily alleviate certain NPS, some have severe and harmful effects [9,10] .Patients with dementia often report multiple NPS, and apathy, depression and anxiety are frequently found to be the most commonly reported symptoms in these patients [11,12] .Delusional symptoms are one of the highest burdens that cause pain to caregivers [13] .It is associated with greater functional impairment, malnutrition, increased risk of bedsores, and higher risk of death [11,14] .Previous studies have shown that AD patients with delusional symptoms have faster cognitive decline and more signi cant changes in language and executive function than patients without delusional symptoms [8] .Delusional symptoms in AD patients involves structural and functional changes in the brain. Studies have found that in addition to gray matter changes, white matter changes are also designed in these person, and parietal and occipital white matter changes have been shown to contribute to the development of delusional misjudgment in AD patients [15] .Several neurobiologically related factors may interact with the development of delusional disorders.For example, subcortical integrity is decreased, mainly manifested by chronic small vessel ischemia and lacunar infarction [16] .…”